Anticholinergic Medications and Cognitive Decline: What the Research Really Shows
Prescription and over-the-counter medications play an important role in treating allergies, bladder problems, depression, sleep difficulties, movement disorders, and many other health conditions.
However, some medicines have what are known as anticholinergic effects. These drugs reduce the action of acetylcholine, a chemical messenger involved in memory, attention, muscle activity, and other functions.
Researchers have been studying whether long-term exposure to medications with stronger anticholinergic activity may be associated with a greater risk of cognitive decline, mild cognitive impairment, or dementia in some older adults.
The findings are important, but they need to be interpreted carefully. An association does not necessarily prove that a medication directly causes dementia, and people should never stop a prescribed medicine suddenly because of an online article.
What Are Anticholinergic Medications?
Anticholinergic medications block or reduce the activity of acetylcholine in the nervous system.
Depending on the drug, this action can be useful for treating conditions such as:
- Overactive bladder
- Motion sickness
- Parkinsonian symptoms
- Some respiratory conditions
- Certain gastrointestinal disorders
- Some forms of depression
- Allergies
- Sleep problems
Some medications are strongly anticholinergic, while others have only mild anticholinergic activity.
This distinction matters because not every drug used for allergies, blood pressure, or depression belongs to the same risk category.
Why Researchers Are Concerned
Acetylcholine plays an important role in learning and memory.
Because anticholinergic medicines reduce acetylcholine activity, researchers have long known that some of these drugs can temporarily cause side effects such as:
- Confusion
- Drowsiness
- Difficulty concentrating
- Memory problems
- Dry mouth
- Constipation
- Blurred vision
These effects can be especially noticeable in older adults, whose brains may be more sensitive to medication-related cognitive effects.
What One Long-Term Study Found
A study involving hundreds of older adults examined whether the use of medications with anticholinergic activity was associated with cognitive decline over time.
The participants were cognitively normal at the beginning of the research and underwent regular cognitive testing during follow-up.
The researchers found that people using at least one medication with anticholinergic properties had a higher likelihood of developing mild cognitive impairment compared with people who were not using such medications.
The association appeared stronger among people who already had genetic or biological markers associated with Alzheimer’s disease.
However, this kind of observational research cannot prove that the medication itself was the sole cause of later cognitive decline.
The most important takeaway is not to fear every medication, but to understand that the total “anticholinergic burden” may matter—especially in older adults taking several medicines at the same time.
